DWM
ABEO icon

Darwin Wealth Management’s Abeona Therapeutics ABEO Stock Holding History

Darwin Wealth Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116 Hold
26
– – ﹤0.01% 585
2025
Q4 		$137 Hold
26
– – ﹤0.01% 630
2025
Q3 		$137 Hold
26
– – ﹤0.01% 581
2025
Q2 		$147 Hold
26
– – ﹤0.01% 583
2025
Q1 		$144 Hold
26
– – ﹤0.01% 617
2024
Q4 		$144 Hold
26
– – ﹤0.01% 617
2024
Q3 		$164 Buy
+26
New +$136 ﹤0.01% 623

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Darwin Wealth Management's ABEO Position: Q1 2026 in Review

Darwin Wealth Management held its Abeona Therapeutics (ABEO) position steady in Q1 2026 at 26 shares worth $116. The position accounts for ﹤0.01% of the portfolio, ranked #585.

Darwin Wealth Management first reported a position in ABEO in Q3 2024 and has held it in 7 quarters since. The position peaked at $164 in Q3 2024. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Darwin Wealth Management held 26 shares of Abeona Therapeutics worth $116 as of Q1 2026.
  • Darwin Wealth Management left its Abeona Therapeutics share count unchanged in Q1 2026.
  • Abeona Therapeutics made up ﹤0.01% of Darwin Wealth Management's portfolio in Q1 2026, its #585 holding.
  • Darwin Wealth Management first reported a position in Abeona Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Darwin Wealth Management's Abeona Therapeutics position peaked at $164 in Q3 2024.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Darwin Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.